Table_1_Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2− Breast Cancer Patient With High Tumor Mutational Burden.xlsx by Rong Wang (59795)

“…Here we present a case of an ER+/HER2- but TMB-high mBC patient who had significant response to combination therapy with anti-PD-1 antibody camrelizumab and vinorelbine and obtained partial response (PR) with a progression-free survival (PFS) of 5 months after failure of multiple lines of therapy. …”

Ingenuity pathway analysis of DEGs. by Foluwasomi A. Oyefeso (15999113)

Detection, selection and exclusion steps of the cases. by Medine Gözde Üstündağ (21011549)

Subjects:

LPS up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

Baseline characteristics of development and validation sets stratified per observed outcome (complete-case populations). by Truc Sophia Dinh (9403896)

Insufficient disulfide bond formation results in a decrease in alkaline phosphatase activity and accumulation of the reduced form of DegP in LCFA-utilizing cells. by Kanchan Jaswal (9542107)

“…<i>(E) The reduced form of DegP accumulates significantly in oleate-grown cells</i>. …”

Global and five SDI regions’ leukemia burden trends, 1990-2021. by Chengjun Hu (588206)

Subjects:

Spatial-temporal and genomic analysis of typhoid fever cases (burden) in Samoa from April 2018 through June 2020. by Michael J. Sikorski (1832986)

Dose- and time-dependent effect of IFN-γ and TNF-α on benzamil-sensitive <i>I</i>_sc and TEER in HBECs. by Anusree Sasidharan (19226521)

DEGs between Landrace and Tongcheng pigs that are in genomic regions with strong selective sweep signals. by Yalan Yang (735975)

The correlation between the results of qRT-PCR and those DEGs selected from RNA-seq. by Chunmiao Jiang (4634992)

The change of disease burden of CRD by age groups in Fujian, 1990-2021. by Yanrong Yin (14292683)

Subjects:

Gender and age structure analysis of the global burden of disease for subarachnoid hemorrhage in 2021. by Wanyue Li (5800730)

Subjects:

Conditions’ burden influenced by OSA: PAF and number of cases/year among general adult population in Italy (aged 15–74 years). by Ludovica Borsoi (12575042)

Predictive analysis on the cases number of incidence, prevalence, deaths, and DALYs with MAFLD among WCBA to 2040. by Jiaxing Li (113609)

All-age cases and age-standardized incidence, prevalence, deaths, DALYs, YLDs and YLLs rates in 2021 for stomach cancer in China. by Zhouwei Zhan (18471500)

Subjects:

Covid-19 costs per case by characteristics. by Medine Gözde Üstündağ (21011549)

Subjects:

IFNγ up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

IL-4 up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

The DEG number and clustering analysis of DEG expression profile. by Xiaohua Du (1863520)

“…Each column represents one sample, and each row represents one DEG. Red indicates increased expression, and blue indicates decreased expression.…”